Increased oncogenic signaling via the PI3K/Akt/mTOR and MAPK/ERK pathways, along with increased reactive oxygen species (ROS) production have been shown to contribute to the metabolic reprogramming of glioma cells, leading to constitutive HIF signaling (reviewed in ref. [40]). Here, MTOR is linked to central nervous system cancer.